Ultime notizie per Quantum BioPharma (NASDAQ:QNTM) Azioni

Quantum BioPharma

Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares

Quantum BioPharma Ltd

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Biogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) with a Buy and maintains $187 price target.

News

Price Target

Reiteration

Analyst Ratings

BIIB

HC Wainwright & Co. Reiterates Buy on Biogen, Maintains $187 Price Target

Citigroup analyst Keith Horowitz upgrades Truist Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) from Neutral to Buy and raises the price target from $44 to $55.

Upgrades

Citigroup Upgrades Truist Finl to Buy, Raises Price Target to $55

Citigroup analyst Asiya Merchant initiates coverage on SanDisk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDK#NASDAQ">SNDK</a>) with a Buy rating and announces Price Target of $57.

Initiation

SNDK

Citigroup Initiates Coverage On SanDisk with Buy Rating, Announces Price Target of $57

Cryptocurrency markets are holding steady on Thursday morning, with attention shifting to the $20 billion options expiry on June 28 — a key event that could add volatility as <a href="https://www.benzinga.com/money/bitcoin-price-prediction">Bitcoin eyes the $110,000 level.</a>
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Ticker</td>
<td>Price</td>
</tr>
<tr>
<td>Bitcoin</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$107,349.08</td>
</tr>
<tr>
<td>Ethereum</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,447.00</td>
</tr>
<tr>
<td>Solana</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$143.53</td>
</tr>
<tr>
<td>XRP</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.17</td>
</tr>
<tr>
<td>Dogecoin</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1617</td>
</tr>
<tr>
<td>Shiba Inu</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001148</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows Bitcoin and Ethereum large transaction volume increased 5.2% and declined 15.3% respectively. Daily active addresses were down by 2.4% for BTC and up by 14.9% for ETH.</li>
<li>Coinglass data shows 77,362 traders were liquidated in the past 24 hours for $222.89 million.</li>
<li>SoSoValue data shows net inflows of $547.7 million into spot Bitcoin ETFs on Wednesday, while Spot Ethereum ETFs saw net inflows of $60.4 million.</li>
</ul>
Trader Notes: Crypto trader CRG notes that Bitcoin has surged 10% over the past three days, reclaiming momentum after recent volatility. 
It has already taken out the inside bar low and is now approaching the inside bar high.
However, CRG cautions that a pullback to the low $100,000s is still possible and wouldn't invalidate the bullish structure. 
This makes the upcoming weekly close critical, a strong finish could allow room for a healthy correction early next week.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> what a bounce, +10% in 3 days Took out the inside bar low&#8230;. inside bar high is next draw, not entirely sure on timeframe or path though Risk here is that BTC could pull back deep to even low $100ks and still look great&#8230; so just be cognisant Weekly close gonna be an… <a href="https://t.co/7ngr53a7gZ">pic.twitter.com/7ngr53a7gZ</a>
&mdash; CRG (@MacroCRG) <a href="https://twitter.com/MacroCRG/status/1938178379984867685?ref_src=twsrc%5Etfw">June 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Michael van de Poppe <a href="https://x.com/CryptoMichNL/status/1938179180522602754">said</a> Ethereum is positioning for a major breakout. 
ETH is currently testing resistance versus BTC and looks ready to reclaim a key level in its previous range. 
If successful, a quick move to $3,000 is on the table.
Rose Premium Signals <a href="https://x.com/VipRoseTr/status/1938180642681811450">pointed</a> to XRP testing a descending trendline after a strong bounce from support, suggesting a bullish breakout may be nearby. 
A confirmed break above that line could ignite a rally toward $2.4558 and $2.6549, with a retest offering ideal risk-reward setup.
Popular trader Altcoin Gordon teased, "Are you ready for Solana Summer?" in a recent post, hinting that SOL may be gearing up for a seasonal rally. 
With building momentum and growing technical and fundamental support, the stage may be set for SOL to outperform in the weeks ahead.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Quant sent me this for <a href="https://twitter.com/search?q=%24SOL&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$SOL</a>. Are you ready for Solana Summer? <a href="https://t.co/OjzIgAmAdO">pic.twitter.com/OjzIgAmAdO</a>
&mdash; Gordon (@AltcoinGordon) <a href="https://twitter.com/AltcoinGordon/status/1938150702645448848?ref_src=twsrc%5Etfw">June 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The Cryptomist <a href="https://x.com/Thecryptomist/status/1937875856950489547">sees</a> Dogecoin forming an ascending triangle pattern. A breakout from the structure could propel DOGE to $0.82, though the coin currently lags behind its large-cap peers in performance.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46102135/bitcoin-ethereum-xrp-holders-sitting-on-profits-while-dogecoin-trails-report">Bitcoin, Ethereum, XRP Holders Sitting On Profits, While Dogecoin Trails: Report</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$SHIB

$SOL

$XRP

Bitcoin, Ethereum, XRP Hold Steady As Dogecoin Slips Ahead Of Key Options Expiry

HC Wainwright &amp; Co. analyst Andrew Fein reiterates ACADIA Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACAD#NASDAQ">ACAD</a>) with a Buy and maintains $32 price target.

ACAD

HC Wainwright & Co. Reiterates Buy on ACADIA Pharmaceuticals, Maintains $32 Price Target

Barclays analyst Nicholas Campanella initiates coverage on NRG Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) with a Overweight rating and announces Price Target of $197.

Barclays Initiates Coverage On NRG Energy with Overweight Rating, Announces Price Target of $197

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) with a Buy and maintains $3 price target.

CGTX

HC Wainwright & Co. Reiterates Buy on Cognition Therapeutics, Maintains $3 Price Target

<ul>
<li>Three-decade industry leader, former CEO of Karuna and Anthos and Chief Commercial Officer of Allergan, Bill Meury, joins Incyte as President and CEO.</li>
<li>Hervé Hoppenot to retire after 11 years of leading Incyte through major expansion.</li>
<li>Julian Baker elected Chairman of the Board of Directors</li>
</ul>

Biotech

Health Care

Management

General

INCY

Incyte appoints Bill Meury as President, CEO And Board Member, Effective Immediately

<ul>
<li>Demonstrated target engagement and response prediction for ALTO-203 by theta/beta ratio, a commonly used EEG index of cortical arousal and attentional control&nbsp;</li>
<li>ALTO-203, a non-stimulant compound which demonstrated pro-cognitive and wake-promoting effects, has the potential to address sustained attention abnormalities in EEG biomarker characterized patients&nbsp;</li>
<li>Pharmacodynamic activity is aligned with the proposed mechanism of ALTO-203; improvements in attention and corresponding reductions in EEG theta/beta ratio, as well as response prediction biomarker replicate Phase 1 study findings&nbsp;</li>
</ul>

ANRO

Alto Neuroscience Identifies EEG Biomarker And Reports Pharmacodynamic Results From Phase 2 Trial Of ALTO-203 For Major Depressive Disorder

Invenergy, America's largest privately held developer, owner and operator of clean energy solutions, and Meta Platforms, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) today announced they have signed four additional clean energy agreements that represent an additional 791 megawatts (MW) of procured solar and wind energy. The agreements will provide near-term energy to support Meta's operations, data center growth, and clean energy&nbsp;goals.
&nbsp;
The&nbsp;agreements&nbsp;come&nbsp;after&nbsp;the&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4457827-1&amp;h=1523568139&amp;u=https%3A%2F%2Finvenergy.com%2Fnews%2Finvenergy-to-provide-over-760mw-in-renewable-energy-supporting-meta-s-energy-needs-in-line-with-its-clean-and-renewable-energy-goals&amp;a=2024%C2%A0announcement">2024&nbsp;announcement</a> of Meta's 1,000 MW of total procured energy from Invenergy. Together, these projects bring the companies' partnership to a total of 1,800 MW, including over 740 MW of new energy generation in Ohio. The electricity from these projects will be delivered to the local grid, while Meta will receive the clean energy credits associated with the new generation capacity coming online.

Invenergy and Meta Sign Clean Energy Deals for 791 MW to Support Data Centers and Sustainability Goals

Transom Capital Group, LLC ("Transom"), an operationally focused middle-market private equity firm, today announced that it has commenced a cash tender offer to acquire all outstanding shares of common stock of SigmaTron International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMA#NASDAQ">SGMA</a>) (the "Company" or "SigmaTron"), an electronic manufacturing services company, at a price of $3.02 per share in cash. The tender offer is being made in connection with the previously announced Agreement and Plan of Merger, dated May 20, 2025 (as amended or supplemented from time to time, the "Merger Agreement").
Transom Offer Unanimously Recommended by SigmaTron Board&nbsp;of Directors
The SigmaTron Board&nbsp;of Directors (the "SigmaTron Board") unanimously determined that the offer and the merger are advisable and in the best interest of SigmaTron and its stockholders and recommends the stockholders tender their shares to Transom. The SigmaTron Board, with the assistance of its management team and advisors, engaged in a comprehensive review of a range of financial and strategic alternatives and engaged with over thirty parties to determine interest in a transaction. The SigmaTron Board also reviewed a proposal submitted by a third party following the announcement of the Merger Agreement. The third party subsequently communicated to the Company that it was no longer pursuing a transaction and withdrew its proposal.
Cash Consideration Provides Immediate Liquidity and Certainty of Value
The SigmaTron Board took into account various factors, including, among other things, the potential risks related to SigmaTron's significant level of indebtedness and the terms of such indebtedness, in its determination, as described further in SigmaTron's Schedule 14D-9 (as defined below). The SigmaTron Board believed the certainty of value provided by the $3.02 cash offer and the timing in which the transaction could be consummated, among other things, was in the best interests of SigmaTron's stockholders.
Tender Offer Details
On June 26, 2025, Transom filed with the U.S. Securities and Exchange Commission ("SEC") a tender offer statement on Schedule TO, including an offer to purchase and letter of transmittal (the "Schedule TO"), which sets forth the terms of the tender offer. Additionally, SigmaTron filed with the SEC a solicitation/recommendation statement on Schedule 14D-9 (the "Schedule 14D-9") that includes the recommendation of the SigmaTron Board that SigmaTron stockholders accept the tender offer and tender their shares.
The tender offer is scheduled to expire at one minute after 11:59 p.m., Eastern Time, on July 24, 2025, unless extended in accordance with the terms of the tender offer and Merger Agreement. Consummation of the tender offer is subject to customary terms and conditions, including the tender of a number of shares of common stock of SigmaTron which represents at least a majority of the voting power of SigmaTron and the satisfaction of other customary closing conditions. Following the successful closing of the tender offer, Transom will acquire any shares of SigmaTron that are not tendered in the tender offer through a second-step merger for the same consideration as paid in the tender offer.

SGMA

Transom Capital Group Commences Cash Tender Offer To Acquire All Outstanding Common Shares Of SigmaTron At $3.02/Shr In Cash

As the One Big Beautiful Bill Act of 2025 proposes tax relief for individuals, it is also estimated to increase the federal deficit. However, this expert proposes an idea that could help cut trillions of dollars in deficit.
What Happened: Financial commentator Ross Gerber of Gerber Kawasaki has ignited discussion with an X post, proposing to let the &#8220;tax cuts&#8221; expire and restore full State and Local Tax (SALT) deductions to slash the U.S. federal deficit by trillions.
Gerber targets the <a href="https://www.benzinga.com/personal-finance/25/05/45485150/the-one-big-beautiful-bill-would-create-maga-savings-accounts-with-a-1000-gift-from-the-government-at-birth">One Big Beautiful Bill Act</a>, a House-passed bill extending tax cuts and raising the SALT cap to $40,000, which faces Senate hurdles.
The tax cut bill is projected to add $3 trillion to the national debt over a decade, according to the Committee for a Responsible Federal Budget, a cost Gerber's plan seeks to avoid by letting its provisions lapse.
Restoring full SALT deductions—beyond the bill&#8217;s $40,000 limit—could benefit high-tax states like California, where residents often exceed the current $10,000 caps. However, this hinges on new legislation, as the 2017 Tax Cuts and Jobs Act (TCJA) SALT cap remains unless Congress acts.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Let the tax cuts expire and full SALT comes back. That would cut the deficit by trillions. People in California would also save money on taxes.
&mdash; Ross Gerber (@GerberKawasaki) <a href="https://twitter.com/GerberKawasaki/status/1938152101323878461?ref_src=twsrc%5Etfw">June 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/25/06/46109917/billionaire-david-tepper-dumps-nvidia-slashes-magnificent-7-holdings-but-bets-big-on-these-2-ai-and-blockchain-plays">Billionaire David Tepper Dumps Nvidia, Slashes &#8216;Magnificent 7&#8217; Holdings — But Bets Big On These 2 AI And Blockchain Plays</a>
Why It Matters: The estimates released by the Congressional Budget Office for the distributional effects of the One Big Beautiful Bill Act highlighted that tax changes, including extending provisions of the 2017 tax act, would lead to an <a href="https://www.benzinga.com/markets/equities/25/05/45536595/big-beautiful-bill-will-explode-the-deficit-and-make-the-rich-richer-congressional-budget-office-estimates-4-income-fall-for-lowest-decile-of-americans-by-2033">increase in the federal deficit by $3.8 trillion</a>.
Meanwhile, the CBO document also underscores a $698 billion reduction in federal subsidies from changes to the Medicaid program and $267 billion less in federal spending for the Supplemental Nutrition Assistance Program (SNAP).
The document also stated, "Household resources would decrease by an amount equal to about 2 percent of income in the lowest decile (tenth) of the income distribution in 2027 and 4 percent in 2033, mainly as a result of losses of in-kind transfers, such as Medicaid and SNAP."
On the other hand, resources would increase by an amount equal to 4% for households in the highest decile in 2027 and 2% in 2033, mainly because of "reductions in the taxes they owe."
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher in premarket on Thursday. The SPY was up 0.34% at $609.18, while the QQQ advanced 0.46% to $543.64, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46068345/blackrock-bets-big-on-defense-companies-amid-escalating-geopolitical-tensions-palantir-lockheed-martin-northrop-grumman-among-stocks-in-focus" target="_blank" rel="noreferrer noopener">BlackRock Bets Big On Defense Companies Amid Escalating Geopolitical Tensions: Palantir, Lockheed Martin, Northrop Grumman Among Stocks In Focus</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. 
Image via Shutterstock

Ross Gerber Touts An Idea To Cut Deficit By Trillions Of Dollars: 'Let The Tax Cuts Expire And Full SALT Come Back'

ASTS

AST SpaceMobile and Fairwinds Demonstrate World's First Space-Based Tactical Broadband to Standard Smartphones With U.S. Defense Participation

PLMR

Palomar And Neptune Join Forces To Expand Flood Insurance Availability Using AI And Data Science For Streamlined Solutions

BBIO

BridgeBio Says It Will Host Investor Webinar On July 11 Featuring Matthew Wicklund To Discuss LGMD2I/R9 And BBP-418 Phase 3 Program Progress

<ul>
<li>U.S. commercial rollout of novel diagnostic platform to begin second half 2025</li>
<li>Underserved CNS cancer diagnostic U.S. market opportunity estimated to be in excess of $6 billion</li>
</ul>

PSTV

Plus Therapeutics Provides A Business Update For Its Wholly-owned Subsidiary, CNSide Diagnostics, The CNSide Cerebrospinal Fluid Assay Platform Is Designed And Intended For Patients Suspected Of Having Central Nervous System Cancer Metastases

As blockchain technology adoption accelerates and digital assets become part of mainstream portfolios, one question looms large: How do we make these innovations work for everyone—not just early adopters and tech insiders?
Pamella Onoriode, a leading voice in financial inclusion and digital innovation, has made it her mission to answer that question. With a career spanning blockchain education, decentralized finance, and financial literacy for underrepresented communities, she brings both technical fluency and human focus to the conversation.
In this exclusive interview with The Champions Speakers Agency, Onoriode explores the real-world impact of blockchain beyond Bitcoin (BTC), offers practical frameworks for navigating crypto risk, and challenges traditional investing strategies with a bold, cycle-informed approach to long-term financial health.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="680" height="373" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/25162334/Pamella-Onoriode.jpg" alt="" class="wp-image-14896" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/25162334/Pamella-Onoriode.jpg 680w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/25162334/Pamella-Onoriode-300x165.jpg 300w" sizes="(max-width: 680px) 100vw, 680px" /></figure>
<h3 class="wp-block-heading">Q: Beyond Bitcoin, how is blockchain technology being applied to real-world problems?</h3>
Pamella Onoriode: So, blockchain is so much more than Bitcoin. Yes, Bitcoin is the super queen of cryptocurrencies, but here are some amazing use cases:
<ul class="wp-block-list">
<li>Supply chain tracking – making sure that products we buy, for example, from food to fashion, are actually ethically sourced.</li>
<li>Smart contracts – automating agreements, reducing legal costs.</li>
<li>Financial inclusion – again, one of my favorites, is just giving unbanked communities access to money and financial services.</li>
</ul>
And I love blockchain technology because it&#8217;s decentralized power. There&#8217;s no middle human, and it&#8217;s just transparent.
<h3 class="wp-block-heading">Q: What are the key risks and rewards of investing in cryptocurrency today?</h3>
Pamella Onoriode: Yeah, so the benefits are:
<ul class="wp-block-list">
<li>Financial independence – you control your assets.</li>
<li>High growth potential – early adoption can lead to really big returns.</li>
<li>Global accessibility – so there&#8217;s no need for banks.</li>
</ul>
There are challenges, of course:
<ul class="wp-block-list">
<li>It&#8217;s volatile – the market moves really fast.</li>
<li>Security risks – scams and hacks are real.</li>
<li>Regulation uncertainty – you know, governments are still catching up.</li>
</ul>
And I, you know, I tell women: crypto isn&#8217;t just for tech bros. Financial literacy is power, and we should be part of that conversation.
<h3 class="wp-block-heading">Q: From your perspective, what strategies support long-term financial resilience through digital assets?</h3>
Pamella Onoriode: Okay, bear with me, but this is going to sound radical. I bet you&#8217;ve never heard this, right?
<ul class="wp-block-list">
<li>Invest according to your cycle – I make my best decisions in the follicular phase when my brain is at its sharpest. I know that I&#8217;ve been tracking for 15-odd years.</li>
<li>Diversify your portfolio – you&#8217;ve heard this one: don&#8217;t put everything into one coin.</li>
<li>Have a long-term mindset – ignore the hype and focus on fundamentals.</li>
</ul>
You know, I have great pleasure in educating my kids on financial freedom. My sons are little, but I already talk to them about the value of money and assets and long-term thinking. And I want them to grow up knowing that wealth isn&#8217;t just about money – it&#8217;s actually about choices.
This exclusive interview with <a href="https://champions-speakers.co.uk/speaker-agent/pamella-onoriode" target="_blank" rel="noreferrer noopener">Pamella Onoriode</a> was conducted by <a href="https://motivationalspeakersagency.co.uk/author/mark-matthews" target="_blank" rel="noreferrer noopener">Mark Matthews</a> of The Motivational Speakers Agency.

Opinion

Interview

'Crypto Isn't Just For Tech Bros': Pamella Onoriode On Blockchain Technology's Real-World Utility Beyond Bitcoin

DGNX

Diginex Joins S&P Global BMI Index, Signaling Credibility And Enhanced Market Visibility For Institutional Investors

Company recently reported strong Fiscal 2025 earnings growth and Fiscal 2026 growth outlook
Wiley(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLY#NYSE">WLY</a>), a leading provider of authoritative content, data-driven insights, and knowledge services for the advancement of science, innovation and learning, today announced that its Board of Directors has declared a quarterly cash dividend of $0.355 per share on its Class A and Class B Common Stock, payable on July 24, 2025, to shareholders of record on July 8, 2025. The quarterly dividend is equivalent to an annual dividend of $1.42 per share, an increase from $1.41 per share in Fiscal 2025. It is Wiley's 32nd consecutive annual increase.
The Company also announced that its Board of Directors has approved a $250 million share repurchase authorization, an increase from the 2020 authorization of $200 million. In Fiscal 2025, Wiley allocated $76 million and $60 million to dividends and share repurchases, respectively.

Dividends

Buybacks

Wiley Board Approves $250M Share Repurchase Authorization, Increase From 2020 Authorization Of $200M; Raises Annual Dividend From $1.41 To $1.42 Per Share

Orion Energy Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OESX#NASDAQ">OESX</a>) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.05) by 80 percent. This is a 280 percent decrease over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $20.869 million which missed the analyst consensus estimate of $21.181 million by 1.47 percent. This is a 20.98 percent decrease over sales of $26.411 million the same period last year.

Earnings

Earnings Misses

OESX

Orion Energy Sys Q4 EPS $(0.09) Misses $(0.05) Estimate, Sales $20.869M Miss $21.181M Estimate

Press Releases

Quantum BioPharma Partners with BitGo to Securely Store its Crypto Currency Assets

Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

Legal

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients

Quantum BioPharma Clarifies It Has Not Changed Its Name

Quantum Biopharma Purchases More Bitcoin (BTC) Bringing the Total Investment in Digital Assets to USD $5,000,000

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

Financing

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

CSE:QNTM

HUGE

MDCX

QNTM

Comments

Quantum BioPharma

Notizie

Ultime notizie per Quantum BioPharma (NASDAQ:QNTM) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO